When to update COVID-19 vaccine composition-Reference-Cited by-同舟云学术

When to update COVID-19 vaccine composition

Published:2023-02-20 Issue:4 Volume:29 Page:776-780
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Grant Rebecca^ORCID,Sacks Jilian A.^ORCID,Abraham Priya,Chunsuttiwat Supamit,Cohen Cheryl^ORCID,Figueroa J. Peter^ORCID,Fleming Thomas,Fine Paul,Goldblatt David^ORCID,Hasegawa Hideki^ORCID,MacIntrye C. Raina,Memish Ziad A.,Miller Elizabeth,Nishioka Sergio,Sall Amadou A.,Sow Samba,Tomori Oyewale^ORCID,Wang Youchun^ORCID,Van Kerkhove Maria D.^ORCID,Wambo Marie-Ange,Cohen Homa Attar^ORCID,Mesfin Samuel,Otieno James R.^ORCID,Subissi Lorenzo^ORCID,Briand Sylvie,Wentworth David E.,Subbarao Kanta^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-023-02220-y.pdf

Reference25 articles.

1. World Health Organization. https://www.who.int/activities/tracking-SARS-CoV-2-variants (accessed August 2022).

2. Higdon, M. M. et al. Lancet Infect. Dis. 22, 1114–1116 (2022).

3. World Health Organization. https://www.who.int/groups/technical-advisory-group-on-covid-19-vaccine-composition-(tag-co-vac) (accessed August 2022).

4. World Health Organization. https://www.who.int/publications/m/item/who-target-product-profiles-for-covid-19-vaccines (accessed August 2022).

5. Subissi, L. et al. Nat. Med. 28, 1110–1115 (2022).

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Vaccine development and distribution;International Encyclopedia of Public Health;2025

2. SARS‐CoV‐2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations;Advanced Science;2024-08-29

3. Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity—IVY Network, 26 Hospitals, 18 October 2023–9 March 2024;Clinical Infectious Diseases;2024-08-06

4. Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results;Vaccines;2024-07-25

5. SARS-CoV-2 methyltransferase nsp10-16 in complex with natural and drug-like purine analogs for guiding structure-based drug discovery;2024-07-17